Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
文件核验信息(付费前可核对)
标准范围(官方英文摘要)
This document provides generic requirements for evaluating the performance and ensuring the quality of methods used for the quantification of specific nucleic acid sequences (targets).
This document is applicable to the quantification of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) target sequences using either digital (dPCR) or quantitative real-time PCR (qPCR) amplification technologies. It applies to target sequences present in nucleic acid molecules including double-stranded DNA (dsDNA) such as genomic DNA (gDNA) and plasmid DNA, single stranded DNA (ssDNA), complementary DNA (cDNA), and single stranded RNA (ssRNA) including ribosomal RNA (rRNA), messenger RNA (mRNA), and long and short non-coding RNA [microRNAs (miRNAs) and short interfering RNAs (siRNAs)], as well as double-stranded RNA (dsRNA).
This document applies to nucleic acids derived from biological sources such as viruses, prokaryotic and eukaryotic cells, cell-free biological fluids (e.g. plasma or cell media) or in vitro sources [e.g. oligonucleotides, synthetic gene constructs and in vitro transcribed (IVT) RNA].
This document is not applicable to quantification of very short DNA oligonucleotides (<50
标准信息
- 标准号
- ISO 20395:2019
- 英文标题
- Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
- 发布单位
- —
- 技术委员会
- ISO/TC 276/SC 1
- 版本 / 版次
- 1
- 状态
- 现行
- 发布日期
- 2019
- ICS 分类
- 07.080 生物学、植物学、动物学
- 页数
- 50 页
- 官方定价
- CHF 173
同分类下的其他标准
相关标准
怎么获取 ISO 20395:2019 全文
这份标准属于 ISO/IEC 发布,全文 50 页,语言为 EN。如果你只需要核对条款、做合规对照或者写方案引用,直接在线支付 3 元即可获得 PDF 全文,支付成功后立即给出下载链接(24 小时内有效,之后凭购买记录也能随时重新下载,不再收费)。
如果你要长期、大量使用这类标准,包年会员更合适:39 元一年每天可下 10 份,69 元一年每天 50 份,999 元一年不限次数。会员下载过的标准可以随时免费重下,不占用每日次数。按单份均价 3 元估算,一年下 13 份以上就已经回本。
需要注意的是,标准正文的著作权归 ISO、IEC 及各国家成员体所有。本站提供的是文献检索与代传服务,建议在正式项目、投标或认证场景中同时通过官方渠道核验标准的最新版本,避免使用已废止版本造成合规风险。